Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease

NCT00976118 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: masitinib (AB1010)
DRUG: placebo

Sponsor

AB Science